Cell and Gene Therapy Market Size, Business Opportunity and Future Demand by 2028 | IMARC Group

IMARC Group, a leading market research company, has recently releases report titled "𝐂𝐞𝐥𝐥 𝐚𝐧𝐝 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟑-𝟐𝟎𝟐𝟖." The study provides a detailed analysis of the industry, including the global cell and gene therapy market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the cell and gene therapy market?

The global cell and gene therapy market size reached US$ 15.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 43.0 Billion by 2028, exhibiting a growth rate (CAGR) of 17.4% during 2023-2028.

What is cell and gene therapy?

Cell and gene therapy represents a pioneering approach to medical treatment that harnesses the potential of cellular and genetic interventions to address various health conditions. Differing from traditional medical approaches, cell and gene therapy employs advanced technologies to modify or replace faulty genes or cells within a patient's body. This method holds promise in treating a wide spectrum of diseases, from genetic disorders to certain types of cancer. Healthcare professionals and research institutions are actively utilizing these innovative therapies to provide tailored medical solutions, including personalized gene editing and cell-based regenerative treatments. The versatility and precision of cell and gene therapy offer a transformative avenue for medical advancements, presenting new possibilities for patients and medical practitioners alike.

Request for a sample report or buy full report: https://www.imarcgroup.com/cell-gene-therapy-market/requestsample

What are the growth prospects and trends in the cell and gene therapy industry?

The escalating demand for novel medical interventions, coupled with significant scientific progress, is driving the growth of the cell and gene therapy field. Additionally, healthcare organizations and research establishments are increasingly embracing cutting-edge technologies in this realm to elevate patient care and advance medical boundaries. Amid these developments, cell and gene therapy emerge as dynamic and transformative segments within the broader healthcare landscape, catalyzing the evolution of medical treatments. Moreover, adherence to rigorous regulatory frameworks and a steadfast commitment to ensuring patient safety and ethical considerations play a pivotal role in shaping the trajectory of the cell and gene therapy sector. The facilitation and promotion of these therapies are integral to addressing the evolving healthcare needs of individuals, thereby fostering the sector's expansion. Furthermore, ongoing research and development activities play a fundamental role in advancing these therapies, unlocking new avenues for addressing previously untreatable conditions.

Who are the key players operating in the industry?

The report covers the major market players including:
• Amgen Inc.
• Biogen
• Bluebird bio, Inc.
• Bristol-Myers Squibb
• Gilead Science
• Kolon TissueGene Inc.
• Orchard Therapeutics plc.
• Pfizer Inc
• Renova Therapeutics
• Spark Therapeutics, Inc.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Therapy Type:
• Cell Therapy
o Stem Cell
 Pluripotent Stem Cell
 Cancer Stem Cell
 Adult Stem Cell
o Non-Stem Cell
 T Cells
 Natural Killer
 Others
• Gene Therapy

Breakup by Indication:
• Cardiovascular Disease
• Oncology Disorder
• Genetic Disorder
• Infectious Disease
• Neurological Disorder
• Others

Breakup by Delivery Mode:
• In-Vivo
• Ex-Vivo

Breakup by End User:
• Hospitals
• Cancer Care Centers
• Pharmaceutical & Biotechnology Companies
• Others

Breakup by Region:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=6964&flag=C

Key Highlights of the Report:
• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨s:

IMARC Group

134 N 4th St Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.